Regulation of interleukin (IL)-12 receptor β2 subunit expression by endogenous IL-12: A critical step in the differentiation of pathogenic autoreactive T cells

Journal of Experimental Medicine

Volumn 189, Issue 6, 1999, Pages 969-978

  Chang, John T ^a   Shevach, Ethan M ^a   Segal, Benjamin M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Autoimmunity; CD40 ligand; Experimental allergic encephalomyelitis; Interferon ; T helper cell type 1 lymphocytes

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; MYELIN BASIC PROTEIN; RECEPTOR SUBUNIT;

ALLERGIC ENCEPHALITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; T LYMPHOCYTE;

AMINO ACID SEQUENCE; ANIMALS; CD40 LIGAND; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0033560023     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.6.969     Document Type: Article

References (46)

1. Xu, H., L.V. Rizzo, P.B. Silver, and R.R. Caspi. 1997. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis. Cell. Immunol. 178:69-78.
2. Germann, T., J. Szeliga, H. Hess, S. Storkel, F.J. Podlaski, M.K. Gately, E. Schmitt, and E. Rude. 1995. Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA. 92:4823-4827.
3. Liblau, R.S., S.M. Singer, and H.O. McDevitt. 1995. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:34-38.
4. Romball, C.G., and W.O. Weigle. 1987. Transfer of experimental autoimmune thyroiditis with T cell clones. J. Immunol. 138:1092-1098.
5. Sakaguchi, S., K. Fukuma, K. Kuribayashi, and T. Masuda. 1985. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161:72-87.
6. Sher, A., and R.L. Coffman. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385-409.
7. Zamvil, S.S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579-621.
8. Bergman, B., and K. Haskins. 1994. Islet-specific T-cell clones from the NOD mouse respond to beta-granule antigen. Diabetes. 43:197-203.
9. de Carli, M., M.M. D'Elios, S. Mariotti, C. Marcocci, A. Pinchera, M. Ricci, S. Romagnani, and G. del Prete. 1993. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 77:1120-1124.
10. Navikas, V., and H. Link. 1996. Review: cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:322-333.
11. Simon, A.K., E. Seipelt, and J. Sieper. 1994. Divergent T-cell cytokine patterns in inflammatory arthritis. Proc. Natl. Acad. Sci. USA. 91:8562-8566.
12. Tisch, R., and H. McDevitt. 1996. Insulin-dependent diabetes mellitus. Cell. 85:291-297.
13. Frei, K., H.P. Eugster, M. Bopst, C.S. Constantinescu, E. Lavi, and A. Fontana. 1997. Tumor necrosis factor alpha and lymphotoxin alpha are not required for induction of acute experimental autoimmune encephalomyelitis. J. Exp. Med. 185:2177-2182.
14. Ferber, I.A., S. Brocke, C. Taylor-Edwards, W. Ridgway, C. Dinisco, L. Steinman, D. Dalton, and C.G. Fathman. 1996. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 156:5-7.
15. Krakowski, M., and T. Owens. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. Eur. J. Immunol. 26:1641-1646.
16. Willenborg, D.O., S. Fordham, C.C. Bernard, W.B. Cowden, and I.A. Ramshaw. 1996. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis J. Immunol. 157:3223-3227.
17. Constantinescu, C.S., M. Wysocka, B. Hilliard, E.S. Ventura, E. Lavi, G. Trinchieri, and A. Rostami. 1998. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J. Immunol. 161:5097-5104.
18. McIntyre, K.W., D.J. Shuster, K.M. Gillooly, R.R. Warrier, S.E. Connaughton, L.B. Hall, L.H. Arp, M.K. Gately, and J. Magram. 1996. Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur.J. Immunol. 26:2933-2938.
19. Matthys, P., K. Vermeire, T. Mitera, H. Heremans, S. Huang, and A. Billiau. 1998. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur. J. Immunol. 28:2143-2151.
20. Segal, B.M., B.K. Dwyer, and E.M. Shevach. 1998. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J. Exp. Med. 187:537-546.
21. Leonard, J.P., K.E. Waldburger, and S.J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381-386.
22. Neurath, M.F., I. Fuss, B.L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281-1290.
23. Davidson, N.J., S.A. Hudak, R.E. Lesley, S. Menon, M.W. Leach, and D.M. Rennick. 1998. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 161:3143-3149.
24. Szabo, S.J., N.G. Jacobson, A.S. Dighe, U. Gubler, and K.M. Murphy. 1995. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity. 2:665-675.
25. Szabo, S.J., A.S. Dighe, U. Gubler, and K.M. Murphy. 1997. Regulation of the interleukin (IL)-12Rβ2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 185:817-824.
26. Gately, M.K., L.M. Renzetti, J. Magram, A.S. Stern, L. Adorini, U. Gubler, and D.H. Presky. 1998. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 16:495-521.
27. Segal, B.M., D.M. Klinman, and E.M. Shevach. 1997. Microbial products induce autoimmune disease by an IL-12-dependent pathway. J. Immunol. 158:5087-5090.
28. Segal, B.M., and E.M. Shevach. 1996. IL-12 unmasks latent autoimmune disease in resistant mice. J. Exp. Med. 184: 771-775.
29. Wakatsuki, Y., M.F. Neurath, E.E. Max, and W. Strober. 1994. The B cell-specific transcription factor BSAP regulates B cell proliferation. J. Exp. Med. 179:1099-1108.
30. Wenner, C.A., M.L. Guler, S.E. Macatonia, A. O'Garra, and K.M. Murphy. 1996. Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development. J. Immunol. 156:1442-1447.
31. Grohmann, U., M.L. Belladonna, R. Bianchi, C. Orabona, E. Ayroldi, M.C. Fioretti, and P. Puccetti. 1998. IL-12 acts directly on DC to promote nuclear localization of NF-kappaB and primes DC for IL-12 production. Immunity. 9:315-323.
32. Kappler, J.W., E. Kushnir, and P. Marrack. 1989. Analysis of Vβ17a expression in new mouse strains bearing the Vβa haplotype. J. Exp. Med. 169:1533-1541.
33. Targoni, O.S., and P.V. Lehmann. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187:2055-2063.
34. Magram, J., S.E. Connaughton, R.R. Warrier, D.M. Carvajal, C.Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D.A. Faherty, and M.K. Gately. 1996. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity. 4:471-481.
35. Gerritse, K., J.D. Laman, R.J. Noelle, A. Aruffo, J.A. Ledbetter, W.J. Boersma, and E. Claassen. 1996. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl. Acad. Sci. USA. 93:2499-2504.
36. Samoilova, E.B., J.L. Horton, H. Zhang, and Y. Chen. 1997. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation. J. Mol. Med. 75:603-608.
37. D'Andrea, A., M. Aste-Amezaga, N.M. Valiante, X. Ma, M. Kubin, and G. Trinchieri. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon γ production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041-1048.
38. Encinas, J.A., M.B. Lees, R.A. Sobel, C. Symonowicz, J.M. Greer, C.L. Shovlin, H.L. Weiner, C.E. Seidman, J.G. Seidman, and V.K. Kuchroo. 1996. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J. Immunol. 157:2186-2192.
39. Butterfield, R.J., J.D. Sudweeks, E.P. Blankenhorn, R. Korngold, J.C. Marini, J.A. Todd, R.J. Roper, and C. Teuscher. 1998. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J. Immunol. 161:1860-1867.
40. Harrington, C.J., A. Paez, T. Hunkapiller, V. Mannikko, T. Brabb, M. Ahearn, C. Beeson, and J. Goverman. 1998. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity. 8:571-580.
41. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287-296.
42. Martin, R., R. Voskuhl, M. Flerlage, D.E. McFarlin, and H.F. McFarland. 1993. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis. Ann. Neurol. 34:524-535.
43. Pelfrey, C.M., L.R. Tranquill, A.B. Vogt, and H.F. McFarland. 1996. T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls. Mult. Scler. 1:270-278.
44. Pette, M., K. Fujita, B. Kitze, J.N. Whitaker, E. Albert, L. Kappos, and H. Wekerle. 1990. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology. 40:1770-1776.
45. Jingwu, Z., R. Medaer, G.A. Hashim, Y. Chin, E. van den Berg-Loonen, and J.C. Raus. 1992. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: precursor frequency, fine specificity, and cytotoxicity. Ann. Neurol. 32:330-338.
46. Voskuhl, R.R., R. Martin, and H.F. McFarland. 1993. A functional basis for the association of HLA class II genes and susceptibility to multiple sclerosis: cellular immune responses to myelin basic protein in a multiplex family. J. Neuroimmunol. 42:199-207.